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Abstract
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy is a rare recessive autoimmune disorder caused by a
defect in a single gene called AIRE (autoimmune regulator). Characteristics of this disease include a variable combination of
autoimmune endocrine tissue destruction, mucocutaneous candidiasis and ectodermal dystrophies. The development of Aire-
knockout mice has provided an invaluable model for the study of this disease. The aim of this review is to brieﬂy highlight the
strides made in APECED research using these transgenic murine models, with a focus on known roles of Aire in
autoimmunity. The ﬁndings thus far are compelling and prompt additional areas of study which are discussed.
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Introduction
Autoimmune polyendocrinopathy candidiasis ecto-
dermal dystrophy (APECED), also known as auto-
immune polyglandular syndrome Type I (APS I), is a
rare autosomal recessive disorder that is characterized
by autoimmunity against organ-speciﬁc autoantigens
(Ahonen 1985, Straub and Manns 1998, Aaltonen
and Bjorses 1999). The disease affects primarily
endocrine organs causing a number of conditions that
include adrenocortical and ovarian failure, insulin-
dependent diabetes, hypoparathyroidism and hepatitis
(Ahonen 1985, Clemente et al. 1997, Straub and
Manns 1998, Aaltonen and Bjorses 1999). This
syndrome is also characterized by immunodeﬁciency
as exempliﬁed by enhanced susceptibility of patients
to infection and development of chronic mucocuta-
neous candidiasis (Ahonen 1985, Straub and Manns
1998, Aaltonen and Bjorses 1999). The disorder is
prevalent among Finns, Sardinians, and Iranian Jews
and usually manifests during childhood with
additional pathological conditions emerging later in
life (Shapiro et al. 1987, Straub and Manns 1998,
Bjorses et al. 1996, Rosatelli et al. 1998). APECED is
treated by tackling the speciﬁc problems of the
disease, such as replacing hormones that are in short
supply, providing immunosuppressive therapy and
treating the Candida albicans infection (Ahonen et al.
1986, Faulds et al. 1993, Seidman et al. 1990). There
is no known cure at present for APECED.
Usually autoimmune diseases involve defects in
severalgenes,suchasthosethatencodeT-cellreceptors,
immunoglobulinsandcytokines.APECEDisuniquein
that it is caused by a mutation in a single gene. A
positional cloning approach aided the identiﬁcation of
the autoimmune regulator gene AIRE (Nagamine et al.
1997). This gene, which is localized to chromosome
21 in humans, is split into 14 exons over ,13 kb
(Aaltonen et al. 1994, The Finnish-German APECED
Consortium1997, Nagamineetal.1997).Anumberof
APECED mutations have been identiﬁed so far and
these mutations typically include either single nucleo-
tide substitutions or small insertions/deletions in AIRE
(Pearceetal.1998,Wangetal.1998,Heinoetal.2001,
Podkrajsek et al. 2005). The mutations usually
introduce a premature termination codon, resulting in
a truncated protein, or disrupt one or more of the
functional domains of AIRE (Heino et al. 2001,
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common mutation is a C to T change at nucleotide 889
in exon 6, which results in a premature stop codon
(Wang et al. 1998). A 13 bp deletion in exon 8 (bases
1094–1106) appears to be the second most common
mutation (Pearce et al. 1998, Wang et al. 1998).
The characterization of AIRE
Several genetic and molecular approaches have shed
light on the biochemical nature of AIRE, providing
some insight into the function of this protein. AIRE
encodes a ,57kDa protein composed of ,552 amino
acids (Aaltonen et al. 1994, Nagamine et al. 1997,
Aaltonen and Bjorses 1999). The protein possesses a
nuclear localization domain, an HSR (homogeneously
staining region) homomultimerization domain, a
SAND (Sp100, AIRE-1, NucP41/75, and DEAF-
1/suppressin) domain, 2 plant-homeodomain (PHD)-
type cysteine-rich zinc-ﬁnger domains and four
LXXLL motifs, suggesting a role for this protein as
a transcriptional regulator (Aaltonen and Bjorses
1999, Gibson et al. 1998, The Finnish-German
APECED Consortium 1997). Indeed, experiments
have demonstrated that upon phosphorylation and
dimerization, AIRE binds to DNA sequences that are
known to be recognized by other proteins that, like
AIRE, possess zinc-ﬁnger and leucine-zipper motifs
(Kumar et al. 2001, Purohit et al. 2005). In vitro
experiments including gel-shift assays revealed that
AIRE has a high binding afﬁnity for two sequences—a
TATA-like box (TTATTA) and a tandem repeat of a
G-box (ATTGGTTA) (Kumar et al. 2001, Purohit
et al. 2005). The activation of reporter genes, such as
luciferase and chloramphenicol transacetylase, by
AIRE fused to the GAL4 DNA-binding domain
suggests a transcriptional activation function for AIRE
(Bjorses et al. 2000, Pitka ¨nen et al. 2000). A study has
shown that AIRE also possesses E3 ligase activity,
which facilitates the polyubiquitination of substrates
(Uchida et al. 2004). It has been suggested that the E3
ligase activity is required for the modiﬁcation of
AIRE-interacting proteins so that AIRE can localize
correctly to the site of transcriptional activation
(Uchida et al. 2004). Studies have shown that the
systematic deletion or modiﬁcation of one or more of
the functional domains of AIRE interferes with the
stability, transcriptional activation properties or
nuclear targeting of the protein, highlighting the
importance of each domain (Rinderle et al. 1999,
Bjorseset al.2000,Ramseyet al.2002a, Halonenet al.
2004, Meloni et al. 2005).
The mouse APECED model: Elucidating the
role of Aire
A mouse homolog (Aire) of the human AIRE gene was
identiﬁed and a comparison between the two has
revealed a ,77% nucleotide homology in coding
regions and ,71% protein homology (Antonarakis
et al. 1998, Halonen et al. 1998, Yaspo et al. 1998,
Wang et al. 1999, Blechschmidt et al. 1999). This
prompted the successful development of a mouse
model for APECED to facilitate in-depth studies of
this disease. Aire-deﬁcient mice exhibit characteristics
similar to APECED patients, which include auto-
reacting antibodies against certain organ-speciﬁc
antigens and multi-organ lymphocyte inﬁltration
(Aaltonen and Bjorses 1999, Ramsey et al. 2002b,
Kuroda et al. 2005). As with humans, the endocrine
organs are the main targets of the autoimmune
response in mice resulting in similar phenotypes
(Ramsey et al. 2002b). The mouse model has
therefore enabled further study of the role of Aire in
autoimmunity and studies thus far suggest that the
autoimmune response is likely a result of the
dysregulation in thymocyte clonal deletion of T-cells
within the thymus (negative selection), which is
regulated by Aire.
This view was formally established by the use of
double transgenic mice which were bred to include a
TCR transgene and an Aire null mutation. A failure to
delete the TCR transgene-expressing T-cells demon-
strated the link between Aire and the elimination of
autoreactiveT-cells(Zuklysetal.2000,Andersonetal.
2002, Liston et al. 2003, Park et al. 2003). One such
study traced the fate of hen egg lyzozyme (HEL)-
speciﬁc T-cells, expressed in mice, in the presence or
absence of Aire (Liston et al. 2003). An almost
complete failure to delete autoreactive HEL-speciﬁc
T-cells was observed in knockout mice thymi,
suggesting that Aire regulates the negative selection
of self-reactive T-cells in the thymus (Liston et al.
2003). It has been proposed that such negative
selection is facilitated by promoting the transcription
of a number of self-antigens in thymic medullary
epithileal cells (MECs). These antigens are presented
to developing T-cells and those that are self-reactive
are deleted. The transcriptional control of these
peripheral self-antigens by Aire was hypothesized
because both Aire and the self-antigens are expressed
in MECs (Heino et al. 1999, Zuklys et al. 2000,
Derbinski et al. 2001, Halonen et al. 2001, Anderson
et al. 2002, Adamson et al. 2004). Indeed, a
comparison of gene proﬁles from Aire-knockout
mice with wild-type littermates revealed a lowered
gene expression coding for several peripheral antigens
in MECs from the knockouts, suggesting the require-
ment of Aire for the expression of the self-antigen
(Anderson et al. 2002). However, autoimmunity
against the ubiquitous protein a-fodrin was shown to
occur in Aire-negative mice but the expression of this
protein was retained in the thymi of these knockouts
(Kuroda et al. 2005). This suggests that the role of
Aire in clonal deletion is not limited to the
transcriptional control of self-antigens in the thymus.
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(Tregs) in the TCR-transgenic systems described
above revealed no signiﬁcant difference in cell number
in the Aire-deﬁcient and wild-type backgrounds
(Liston et al. 2003). In vitro and in vivo approaches
also demonstrated that the normal suppressive
function of these cells was retained (Liston et al.
2003). Thus, a deﬁciency in regulatory T-cells or a
defect in their suppressive function does not appear to
be the cause of the central tolerance defect in Aire-
knockout mice.
Aire also appears to exert a quantitative genetic
effect on thymic clonal deletion (Liston et al. 2004).
Levels of HEL mRNAwere measured in different Aire
transgenic mice. Thymic HEL mRNA was absent in
Aire
2/2 mice and levels of this transcript were also
reduced to an intermediate level in Aire
þ/2 hetero-
zygotes when compared to wild-type mice. In
agreement with this data, heterozygosity also had an
impact on the efﬁciency of thymic clonal deletion.
HEL-speciﬁc T-cells were tracked in the thymi ofthese
transgenic mice and a signiﬁcant defect in clonal
deletion was observed in Aire
2/2 mice while an
intermediate defect was seen in Aire
þ/2 mice.
Circulating reactive HEL T-cells were higher in
number in Aire heterozygotes and still higher in Aire
null knockouts when compared to wild-type mice.
This study is in agreement with the observation made
by Sediva and colleagues, whose research showed an
occurrence of a subclinical immune deﬁcit in humans
heterozygous for the AIRE mutation (Sediva et al.
2002). Carriers exhibited higher levels of certain
immunoglobulins (IgA) and activated T-cells when
compared to non-carriers.
In addition to resolving the role of Aire in
autoimmunity, a study by Chin et al focused on
factors that inﬂuence the induction and regulation of
Aire itself. Experimental data suggests that the
expression of Aire is controlled by lymphotoxin
which also mediates lymph node organogenesis and
inﬂammatory responses (Chin et al. 2003). As with
Aire, lymphotoxin is also expressed in the thymi.
Lymphotoxin a and lymphotoxin b-receptor knock-
out mice possess thymi that produce lower levels of
Aire mRNA. However, it is unclear if these results are
a direct effect of lymphotoxin on Aire transcription or
due to a defect in thymi development in these
knockouts.
Conclusions and future directions
Although signiﬁcant advances have been made in our
understanding of the role of Aire in organ-speciﬁc
tolerance, little is known about other functions of this
protein. For instance, the immunodeﬁciency in
APECED cannot be explained simply by the failure
of clonal deletion. The reason for Aire production in
other organs and cells, such as the pancreas and
macrophages respectively, is also unclear but clearly
suggests additional roles of Aire. It would be
interesting to explore the effect of external factors,
such as infection, on the pathogenesis of this disease.
These conditions would more aptly reﬂect scenarios
experienced by APECED patients.
There is some experimental data that addresses
the role of Aire in other areas of immune regulation.
A study by Sato and colleagues showed that Aire
downregulates IL-1 receptor antagonist (IL-1Ra) and
this decrease is due to the competition of Aire for the
transcriptional co-activator CREB-binding protein
(CBP) (Sato et al. 2004). The sequestration of CBP
by Aire results in decreased expression of IL-1Ra
which usually inhibits the biological activity of IL1
that is involved in the defense against Candida albicans.
Thus, in the absence of Aire, IL-1Ra is upregulated,
inhibiting the function of IL-1 and this is likely to
contribute to the immunodeﬁciency observed in
APECED patients. The same study showed that
Aire-expressing cells exhibit a downregulation of
major histocompatibility complex II molecules,
which is important for acquired immunity. This
study highlights that the function of Aire is not limited
to transcriptional activation alone but also involves
repression. Indeed, a recent study using a microarray
approach showed that a number of genes are repressed
by Aire and a subset of these genes encode molecules
other than self-antigens, such as those involved in
antigen presentation (Johnnidis et al. 2005). It would
be interesting to explore further if Aire inﬂuences the
levels and/or functions of additional immune response
cell lineages such as those involved in innate
immunity. Other studies could also pursue the
inﬂuence of Aire on the polarity of the immune
system—this would involve investigating how an Aire
mutation affects the balance between cytokine proﬁle-
based type 1 and type 2 immune responses which
eventually determine if the immune system elicits a
cell-mediated or humoral response. Another avenue of
research that would be of interest to pursue is the role,
if any, of Aire in other autoimmune diseases that are
for instance, based on molecular mimicry—is the
expression or function of Aire affected in such diseases
and if so, how does this contribute to the autoimmune
response.
Although current Aire-knockout systems have
greatly facilitated the study of APECED and the role
of Aire, our understanding is still limited in that the
detailed molecular basis for the changes that occur in
the immune system following an Aire mutation are
unclear. As of now, we have a great deal of insight on
the effect of Aire-deﬁciency on the immune system
since knockouts are born with the defect. If it were
possible to temporally control an Aire mutation during
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would open the door to several avenues of research.
Creating a conditional Aire knockout would permit
such studies. The Cre/lox system has been widely used
to alter target genes in mice (Lakso et al. 1992, Sauer
1998, Dragatsis and Zeitlin 2001). Typically, the
target gene is ﬂanked by LoxP (speciﬁc locus of
crossing over) sites which are recognized by the Cre
recombinase. This enzyme, which is originally from
bacteriophage P1, cleaves DNA at the LoxP site and
catalyzes a recombination reaction effectively deleting
the gene ﬂanked by the two LoxP sites. The strategy to
create a conditional Aire knockout involves generating
two independent transgenic mouse lines: one would
have an inducible promoter that drives the expression
of Cre-recombinase in a speciﬁc cell lineage (for
example, thymus epithelial cells) that produce Aire,
and the other would be homozygous for the target Aire
gene with LoxP sequences introduced at speciﬁc sites
within, or ﬂanking Aire (Figure 1). The progeny of
these two murine lines would allow for Cre-mediated
deletion of Aire, effectively creating an Aire knockout
but only when induced by a speciﬁc agent. By
controlling the age at which the gene can be deleted,
one can monitor what changes occur in the immune
system once the defect is introduced. Other questions
that could be addressed include how abrupt is the
change, how soon do symptoms manifest, and how
age inﬂuences the manifestation of the disease in mice.
In conclusion, APECED is the only known
autoimmune disease in humans that is caused by a
mutation in a single gene. Aire knockout mice exhibit
many symptoms similar to APECED patients and this
has facilitated the study of this disorder in great detail,
leading to an improved understanding of the workings
of the immune system and the autoimmune response.
Elucidating the role of Aire in both autoimmunity and
immunodeﬁciency using murine models is reasoned to
further our understanding of the immune system and
will facilitate the development of future therapeutics.
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